000 02380 a2200745 4500
005 20250517105526.0
264 0 _c20180123
008 201801s 0 0 eng d
022 _a2214-109X
024 7 _a10.1016/S2214-109X(16)30130-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLemoine, Maud
245 0 0 _aAcceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.
_h[electronic resource]
260 _bThe Lancet. Global health
_c08 2016
300 _ae559-67 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAntiviral Agents
650 0 4 _aBlood Donors
650 0 4 _aCommunicable Diseases
650 0 4 _aFeasibility Studies
650 0 4 _aFemale
650 0 4 _aGambia
_xepidemiology
650 0 4 _aHepatitis B
_xdiagnosis
650 0 4 _aHepatitis B Surface Antigens
_xblood
650 0 4 _aHepatitis B virus
_ximmunology
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMass Screening
_xmethods
650 0 4 _aMiddle Aged
650 0 4 _aPoint-of-Care Systems
650 0 4 _aPrevalence
650 0 4 _aSex Factors
700 1 _aShimakawa, Yusuke
700 1 _aNjie, Ramou
700 1 _aTaal, Makie
700 1 _aNdow, Gibril
700 1 _aChemin, Isabelle
700 1 _aGhosh, Sumantra
700 1 _aNjai, Harr F
700 1 _aJeng, Adam
700 1 _aSow, Amina
700 1 _aToure-Kane, Coumba
700 1 _aMboup, Souleymane
700 1 _aSuso, Penda
700 1 _aTamba, Saydiba
700 1 _aJatta, Abdullah
700 1 _aSarr, Louise
700 1 _aKambi, Aboubacar
700 1 _aStanger, William
700 1 _aNayagam, Shevanthi
700 1 _aHowell, Jessica
700 1 _aMpabanzi, Liliane
700 1 _aNyan, Ousman
700 1 _aCorrah, Tumani
700 1 _aWhittle, Hilton
700 1 _aTaylor-Robinson, Simon D
700 1 _aD'Alessandro, Umberto
700 1 _aMendy, Maimuna
700 1 _aThursz, Mark R
773 0 _tThe Lancet. Global health
_gvol. 4
_gno. 8
_gp. e559-67
856 4 0 _uhttps://doi.org/10.1016/S2214-109X(16)30130-9
_zAvailable from publisher's website
999 _c26252066
_d26252066